Drugs / AL-794
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03411421 | Mar → Apr 2018 | — | Alios Biopharma Inc. | Terminated | No outcome recorded |
| Phase 1 | NCT02888327 | Jul 2016 → May 2017 | influenza | Alios Biopharma Inc. | Completed | No outcome recorded |
| Phase 1 | NCT02877160 | Jun 2016 → Feb 2017 | influenza | Alios Biopharma Inc. | Completed | No outcome recorded |
| Phase 1 | NCT02588521 | Aug 2015 → Aug 2017 | influenza | Alios Biopharma Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AL-794 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02877160 ↗ |
| Route | Oral | “administered as tablets orally” NCT03411421 ↗ |